Glucolipsin A and B, two new glucokinase activators produced by Streptomyces purpurogeniscleroticus and Nocardia vaccinii

32Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

During the screening of the natural products for their ability to increase the activity of glucokinase by relieving inhibition by long chain fatty acyl CoA esters (FAC), two novel compounds, glucolipsin A (1) and B (2) were isolated from the butanol extracts of Streptomyces purpurogeniscleroticus WC71634 and Nocardia vaccinii WC65712, respectively. The structures of these two compounds were established by spectroscopic methods and chemical degradation. Glucolipsin A (1) and B (2) relieved the inhibition of glucokinase by FAC with RC50 values of 5.4 and 4.6 μM.

Cite

CITATION STYLE

APA

Qian-Cutrone, J., Ueki, T., Huang, S., Mookhtiar, K. A., Ezekiel, R., Kalinowski, S. S., … Manly, S. P. (1999). Glucolipsin A and B, two new glucokinase activators produced by Streptomyces purpurogeniscleroticus and Nocardia vaccinii. Journal of Antibiotics, 52(3), 245–255. https://doi.org/10.7164/antibiotics.52.245

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free